Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Item
http://www.wikidata.org/entity/Q34526034
Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.Noninvasive predictors of fibrosis in NASH with and without cirrhosis, just as good as histology (and hepatic venous pressure gradient?).Invasive and non-invasive diagnosis of cirrhosis and portal hypertensionEUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study.Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.Hepatic venous pressure gradient: clinical use in chronic liver disease.Assessing portal hypertension in liver diseases.Diagnostic hepatic haemodynamic techniques: safety and radiation exposure.Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient.The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.The interpretation of hepatic venous pressure gradient tracings - excellent interobserver agreement unrelated to experience.Evaluation of portal hypertensive enteropathy by scoring with capsule endoscopy: is transient elastography of clinical impact?Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis.Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.Portal hypertensive enteropathy
P2860

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Item
http://www.wikidata.org/entity/Q34526034
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Assessment of therapeutic bene ...... e gradient a better end point?
@ast
Assessment of therapeutic bene ...... e gradient a better end point?
@en
Assessment of therapeutic bene ...... e gradient a better end point?
@nl
type
label
Assessment of therapeutic bene ...... e gradient a better end point?
@ast
Assessment of therapeutic bene ...... e gradient a better end point?
@en
Assessment of therapeutic bene ...... e gradient a better end point?
@nl
prefLabel
Assessment of therapeutic bene ...... e gradient a better end point?
@ast
Assessment of therapeutic bene ...... e gradient a better end point?
@en
Assessment of therapeutic bene ...... e gradient a better end point?
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Assessment of therapeutic bene ...... e gradient a better end point?
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932